Brigit Biofarmaka Teknologi Tbk. vs Urban Jakarta Propertindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Urban Jakarta Propertindo Tbk. trades at Rp210 (market cap 691.67B, 116.5K 24h volume). The key difference: Urban Jakarta Propertindo Tbk. is far larger — about 4.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Urban Jakarta Propertindo Tbk. is more actively traded (116.5K versus 62.5K). Which is the better fit depends on your goals.
| OBAT | URBN | |
|---|---|---|
Market Cap | 164.65B | 691.67B |
Volume | 62.5K | 116.5K |
Lot | 625 | 1.17K |
Turnover | 15.03M | 24.48M |
Average Price | 240.55 | 210.09 |
Value | 15.03M | 24.48M |
Indicative Equilibrium Price | 238 | 210 |
Indicative Equilibrium Volume | 100 | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Urban Jakarta Propetindo (Company) was established in Jakarta under the framework of ForeignCapital Investment Law No. 1 year 1967 of the Republic of Indonesia as amended and revised by Law No. 11 year 1970, based on the notarial deed No. 62, dated May 9, 1995, of Sinta Susikto, S.H., has been amended several times by notarial deen No. 138 dated October 25, 1995 of the same notary.
Read more on URBN →